Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugh Watson

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
United European Gastroenterology Journal|May 19, 2018
Benzodiazepines and risk for hepatic encephalopathy in patients with cirrhosis and ascitesLisbet Grønbæk, Hugh Watson, Hendrik Vilstrup, et al.
Annals of Hepatology|April 21, 2022
Spontaneous bacterial peritonitis has no effect on the long-term prognosis of cirrhosis patients with ascitesThomas Deleuran, Hugh Watson, Hendrik Vilstrup, et al.
Hepatology (Baltimore, Md.)|July 31, 2016
Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascitesGitte Dam, Hendrik Vilstrup, Hugh Watson, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 7, 2021
Arthralgia resolution rate following chikungunya virus infectionMegan O'Driscoll, Henrik Salje, Aileen Y Chang, et al.
Journal of Hepatology|July 25, 2015
Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patientsPeter Jepsen, Hugh Watson, Per Kragh Andersen, et al.
Clinical Epidemiology|June 27, 2023
Non-Selective Beta-Blockers and Risk of Sepsis in Patients with Cirrhosis and Ascites: Results from a Large Observational StudyMorten Daniel Jensen, Hugh Watson, Hendrik Vilstrup, et al.
Hepatology (Baltimore, Md.)|March 27, 2016
ReplyLars Bossen, Aleksander Krag, Hendrik Vilstrup, et al.
Alimentary Pharmacology & Therapeutics|June 24, 2020
MELD remains the best predictor of mortality in outpatients with cirrhosis and severe ascitesPeter Jepsen, Hugh Watson, Stewart Macdonald, et al.
Musculoskeletal Care|August 20, 2020
Musculoskeletal stiffness is common in healthy adults and increases with ageHugh Watson, Amalie Lynggård Hansen, Giulia Calusi, et al.
Journal of Gastroenterology and Hepatology|December 1, 2018
Serum sodium as a risk factor for hepatic encephalopathy in patients with cirrhosis and ascitesLars Bossen, Pere Ginès, Hendrik Vilstrup, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
United European Gastroenterology Journal|May 19, 2018
Benzodiazepines and risk for hepatic encephalopathy in patients with cirrhosis and ascitesLisbet Grønbæk, Hugh Watson, Hendrik Vilstrup, et al.
Annals of Hepatology|April 21, 2022
Spontaneous bacterial peritonitis has no effect on the long-term prognosis of cirrhosis patients with ascitesThomas Deleuran, Hugh Watson, Hendrik Vilstrup, et al.
Hepatology (Baltimore, Md.)|July 31, 2016
Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascitesGitte Dam, Hendrik Vilstrup, Hugh Watson, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 7, 2021
Arthralgia resolution rate following chikungunya virus infectionMegan O'Driscoll, Henrik Salje, Aileen Y Chang, et al.
Journal of Hepatology|July 25, 2015
Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patientsPeter Jepsen, Hugh Watson, Per Kragh Andersen, et al.
Clinical Epidemiology|June 27, 2023
Non-Selective Beta-Blockers and Risk of Sepsis in Patients with Cirrhosis and Ascites: Results from a Large Observational StudyMorten Daniel Jensen, Hugh Watson, Hendrik Vilstrup, et al.
Hepatology (Baltimore, Md.)|March 27, 2016
ReplyLars Bossen, Aleksander Krag, Hendrik Vilstrup, et al.
Alimentary Pharmacology & Therapeutics|June 24, 2020
MELD remains the best predictor of mortality in outpatients with cirrhosis and severe ascitesPeter Jepsen, Hugh Watson, Stewart Macdonald, et al.
Musculoskeletal Care|August 20, 2020
Musculoskeletal stiffness is common in healthy adults and increases with ageHugh Watson, Amalie Lynggård Hansen, Giulia Calusi, et al.
Journal of Gastroenterology and Hepatology|December 1, 2018
Serum sodium as a risk factor for hepatic encephalopathy in patients with cirrhosis and ascitesLars Bossen, Pere Ginès, Hendrik Vilstrup, et al.
Pageof 6